Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions
- 15 November 2010
- journal article
- Published by Taylor & Francis Ltd in International Journal of Audiology
- Vol. 50 (2), 112-122
- https://doi.org/10.3109/14992027.2010.524253
Abstract
Despite known ototoxic effects of aminoglycoside (AG) antibiotics, audiological assessment is not routinely undertaken in UK CF patients. Consequently, the incidence of hearing loss is not well established. To document the incidence of hearing loss in cystic fibrosis (CF) children. Hearing function of 45 children from Great Ormond Street Hospital was assessed using pure-tone audiometry up to 20kHz and DPOAEs up to 8kHz. 39/45 of participants had received intravenous (IV) AGs, 23 of which received repeated IV AGs every 3 months. In this high exposure group, 8 (21%) had clear signs of ototoxicity; average 8-20kHz thresholds were elevated by ∼50dB and DPOAE amplitudes were >10dB lower at f2 3.2-6.3 kHz. The remaining 31/39 (79%) of AG exposed patients had normal, even exceptionally good hearing. The 21% incidence of ototoxicity we observed is substantial and higher than previously reported. However, our finding of normal hearing in children with equal AG exposure strongly suggests that other unknown factors, possibly genetic susceptibility, influence this outcome. We recommend comparable auditory testing in all CF patients with high AG exposures. Genetic analysis may help explain the dichotomy in response to AGs found.Keywords
This publication has 55 references indexed in Scilit:
- Sensorineural hearing loss in patients with cystic fibrosisOtolaryngology -- Head and Neck Surgery, 2009
- Prevention of noise- and drug-induced hearing loss with d-methionineHearing Research, 2007
- Ototoxicity: Understanding Oxidative MechanismsJournal of the American Academy of Audiology, 2003
- High-Frequency Hearing Influences Lower-Frequency Distortion-Product Otoacoustic EmissionsJAMA Otolaryngology–Head & Neck Surgery, 1999
- A Meta-Analysis of Extended-Interval Dosing Versus Multiple Daily Dosing of AminoglycosidesClinical Infectious Diseases, 1997
- Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosisJournal of Antimicrobial Chemotherapy, 1996
- Single or multiple daily doses of aminoglycosides: a meta- analysisBMJ, 1996
- Current perspectives on inner ear toxicity☆, ☆☆, ★Otolaryngology -- Head and Neck Surgery, 1995
- Recommended procedure for tympanometry: British Society of AudiologyBritish Journal of Audiology, 1992
- Drug-induced OtotoxicityDrugs, 1980